According to analysts' consensus price target of $69.43, Albireo Pharma has a forecasted upside of 73.6% from its current price of $39.99. 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Albireo Pharma in the last year. Huron Capital formed Albireo in 2014 with the goal of building a leading company in the fast-growing energy efficiency, building automation and energy management markets in the U.S. Benefits information above is provided anonymously by current and former Albireo Energy employees, and may include a summary provided by the employer. Get daily stock ideas top-performing Wall Street analysts. Learn about Albireo Energy , including insurance benefits, retirement benefits, and vacation policy. This company Albireo heading toward what it calls "arguably the most important moment in the history of our company," it's offering info encouraging enough for Baird to make the company a Fresh Pick with more than 100% upside to 52%. Compare momentum and price performance. EDISON, N.J., Jan. 14, 2020 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced the addition of … MarketBeat just released five new trading ideas, but Albireo Pharma wasn't one of them. Stock analysis for Albireo Pharma Inc (BDQN) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ET by Tomi Kilgore. 57.21% of the stock of Albireo Pharma is held by institutions. This exciting partnership will strengthen Albireo Energy's geographic presence in the Southeast region by adding seven offices throughout Alabama, Tennessee and Florida. Albireo Pharma is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021. EDISON, N.J., Dec. 10, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced the addition of … Albireo Pharma Inc () Stock Market info Recommendations: Buy or sell Albireo Pharma stock? Albireo Pharma Inc is a development-stage pharmaceutical company. MarketBeat's community ratings are surveys of what our community members think about Albireo Pharma and other stocks. Free forex prices, toplists, indices and lots more. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). ALBIREO PHARMA, INC. : News, information and stories for ALBIREO PHARMA, INC. | Nasdaq: ALBO | Nasdaq There are currently 8 buy ratings for the stock. This exciting partnership will strengthen Albireo Energy's geographic presence in the Southeast region by adding seven offices throughout Alabama, Tennessee and Florida. It engages in the research and development of drug reformulation technology. One share of ALBO stock can currently be purchased for approximately $39.83. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. The company's filing status is listed as Active and its File Number is E6826862020-3. Company profile page for Albireo Ltd including stock price, company news, press releases, executives, board members, and contact information Specifically, they have bought $0.00 in company stock and sold $18,048.00 in company stock. Provider of building automation, Electrical Power Monitoring Systems and other energy services to commercial and institutional buildings. The P/E ratio of Albireo Pharma is -6.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. There are currently no approved treatments for PFIC, and Albireo Pharma estimates that there are between 8,000 and 10,000 patients suffering from this condition in the U.S. and Europe. The all-time high Albireo Pharma stock closing price was 2998.20 on January 09, 2008.; The Albireo Pharma 52-week high stock price is 49.00, which is 19.7% above the current share price. The biopharmaceutical company had revenue of $2.13 million for the quarter, compared to analysts' expectations of $1.90 million. Their forecasts range from $52.00 to $81.00. Company profile page for Albireo Energy LLC including stock price, company news, press releases, executives, board members, and contact information Company insiders that own Albireo Pharma stock include Jason Duncan, Life Sciences Maste Perceptive, Martha J Carter, Pamela Stephenson, Patrick Taylor Horn, Perceptive Advisors Llc and Simon NR Harford. Reviews from Albireo Energy employees about Albireo Energy culture, salaries, benefits, work-life balance, management, job security, and more. Albireo Pharma, Inc. (ALBO) Q3 2019 Earnings Call Transcript Albireo Pharma, Inc. (ALBO) Q2 2019 Earnings Call Transcript Why Albireo Pharma Stock … View insider buying and selling activity for Albireo Pharma or or view top insider-buying stocks. The official website for Albireo Pharma is www.albireopharma.com. Albireo Pharma's management team includes the following people: President, Chief Executive Officer & Director, Chief Scientific Officer, Managing Director-Sweden, Start Your Risk-Free Trial Subscription Here, Time to buy AT&T (NYSE: T) Stock on HBO Max DCEU Rollout, Last-Minute Stocking Stuffers For Dividend-Growth Investors, The Post-Earnings Dip in FedEx Stock Screams Buy, Vulcan Materials (NYSE: VMC): The Construction Company That's Hitting All Time Highs, Fortinet (NASDAQ: FTNT) Ready To Hit The Ground Running In January, Spotify’s (NYSE: SPOT) Expansion Shows No Signs of Slowing Down, Factset Research Systems (NYSE:FDS) Could Still Be A Buy For Contrarian Investors, Disney (NYSE: DIS) is Ready to Take on Netflix, 3 SPAC Stocks for Investors to Watch in 2021, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. 16 Albireo Energy reviews. Albireo submits U.S. and European applications for odevixibat in liver disease Dec. 09, 2020 12:03 AM ET Albireo Pharma, Inc. (ALBO) By: Mamta Mayani , SA News Editor (Add your “underperform” vote.). Shares of ALBO can be purchased through any online brokerage account. Identify stocks that meet your criteria using seven unique stock screeners. It pipeline products include Odevixibat, A3384, and Elobixibat. What is difficult to overlook is if news is coming as the company suggests due in weeks - you must conclude from this chart that... Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Shares of Albireo Pharma (NASDAQ:ALBO) are up by 41.4% as of 11:49 a.m. EDT on Tuesday, after soaring by as much as 79% earlier today. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. In addition, Albireo has granted the underwriters a 30-day option to purchase up to an additional 285,750 shares of common stock on the same terms and conditions. Albireo Energy (AE) provides building automation solutions and energy services to commercial and institutional buildings nationally. Learn everything you need to know about successful options trading with this three-part video course. Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). The company has 4 principals on record. You may vote once every thirty days. Find real-time ALBO - Albireo Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. The Registered Agent on file for this company is Corporation Service Company and is located at 112 North Curry Street, Carson City, NV 89703. All rights reserved. The biopharmaceutical company reported ($1.96) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($1.51) by $0.45. Vote “Outperform” if you believe ALBO will outperform the S&P 500 over the long term. Earnings for Albireo Pharma are expected to decrease in the coming year, from ($7.45) to ($8.43) per share. Pamela Stephenson joined Albireo in March 2019 as Chief Commercial Officer. ALBO stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Victory Capital Management Inc., State Street Corp, Morgan Stanley, Charles Schwab Investment Management Inc., Wells Fargo & Company MN, Dupont Capital Management Corp, and MAI Capital Management. The biopharmaceutical company can be reached via phone at (857) 254-5555 or via email at [email protected]. Albireo Pharma trades on the NASDAQ under the ticker symbol "ALBO.". 8 brokers have issued 1 year price targets for Albireo Pharma's shares. The consensus among Wall Street equities research analysts is that investors should "buy" Albireo Pharma stock. This is useful in estimating the financial strength and credit risk of the company. ALBIREO PHARMA, INC. : Financial news and information Stock ALBIREO PHARMA, INC. | Nasdaq: ALBO | Nasdaq EDISON, N.J., Aug. 20, 2019 — Building automation and energy services provider Albireo Energy, LLC (“Albireo Energy”) today announced the addition of Environmental Energy Corporation (“EEC”) to its already thriving New York division. (Add your “outperform” vote. Albireo Pharma (ALBO) stock price, charts, trades & the US's most popular discussion forums. View analysts' price targets for Albireo Pharma or view Wall Street analyst' top-rated stocks. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. View which … Sign-up to receive the latest news and ratings for ALBO and its competitors with MarketBeat's FREE daily newsletter. Mar. Albireo Prices Public Offering of 4,000,000 Shares of Common Stock BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a … See what's happening in the market right now with MarketBeat's real-time news feed. Want to see which stocks are moving? View which stocks are hot on social media with MarketBeat's trending stocks report. ALBO stock was acquired by a variety of institutional investors in the last quarter, including Federated Hermes Inc., Perceptive Advisors LLC, Sphera Funds Management LTD., GW&K Investment Management LLC, Samsara BioCapital LLC, Engineers Gate Manager LP, DekaBank Deutsche Girozentrale, and BlackRock Inc.. Company insiders that have bought Albireo Pharma stock in the last two years include Life Sciences Maste Perceptive, and Perceptive Advisors Llc. A high-level overview of Albireo Pharma, Inc. (ALBO) stock. Moving Average Convergence Divergence (MACD). View which stocks have been most impacted by COVID-19. Please log in to your account or sign up in order to add this asset to your watchlist. The all-time high Albireo Pharma stock closing price was 2998.20 on January 09, 2008.; The Albireo Pharma 52-week high stock price is 49.00, which is 19.7% above the current share price. Receive a free world-class investing education from MarketBeat. The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as … View Albireo Pharma, Inc. ALBO investment & stock information. BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has added its eleventh company, Alabama Controls, Inc. ("ACI"), to its platform. Albireo Energy is a holding company established to provide a holistic approach to energy efficiency services and smart building solutions to commercial and institutional customers throughout the U.S. Albireo partners with commercial building owners and managers to reduce operational costs and improve building performance with turnkey building automation and monitoring services. 3, 2020 at 7:39 a.m. BOSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel … View analyst ratings for Albireo Pharma or view MarketBeat's top 5 stock picks. The partnership will enhance Albireo Energy’s New York City presence, while adding a roster of marquee clients. Export data to Excel for your own analysis. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Pamela has more than 20 years of biopharma commercial leadership experience across multiple functions and disease areas. EDISON, N.J., Dec. 10, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced the addition of Quality Building Controls, Inc. ("QBC") to its expanding national reach. BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has added its eleventh company, Alabama Controls, Inc. ("ACI"), to its platform. Albireo is a professional energy manager that has the deep market expertise and state-of-the-art technology to help you become benchmark compliant, find energy saving solutions, and make energy purchasing a breeze. View ALBO's latest 10K form and other filings with the Securities and Exchange Commission at MarketBeat. Get the latest Albireo Pharma, Inc. ALBO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Since then, ALBO stock has increased by 125.9% and is now trading at $39.83. BOSTON - Albireo Pharma, Inc. , a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an... | December 14, 2020 Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Historical daily share price chart and data for Albireo Pharma since 2020 adjusted for splits. The company product portfolio includes Pediatric Liver, Adult Liver, and Gastrointestinal. View all of ALBO's competitors. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation and energy management. Albireo Pharma's mailing address is 10 POST OFFICE SQUARE SUITE 502 SOUTH, BOSTON MA, 02109. Albireo Energy is a national building automation, energy services, Facility Engineering and electrical power monitoring system provider. BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has … Albireo Pharma Inc () Stock Market info Recommendations: Buy or sell Albireo Pharma stock? Even better, these stocks are seen as Strong Buys by Wall Street’s analysts. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. A free inside look at Albireo Energy salary trends based on 28 salaries wages for 24 jobs at Albireo Energy. View insider buying and selling activity for Albireo Pharma or view top insider-selling stocks. Albireo Pharma has received a consensus rating of Buy. View our earnings forecast for Albireo Pharma. Fundamental company data provided by Morningstar and Zacks Investment Research. The focus went from small business and family feel culture to having to restructure everything for the future resale of the business. Compare how recession-proof Albireo Energy is relative to the industry overall. The company offers service portfolio, which includes energy efficiency, demand response, and smart building software including building automation, systems integration, metering and lighting. NRG Energy, Inc. Common Stock (NRG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Albireo Energy General Information Description. View our full suite of financial calendars and market data tables, all for free. Based on aggregate information from My MarketBeat watchlists, some companies that other Albireo Pharma investors own include Energy Transfer (ET), Heat Biologics (HTBX), Amarin (AMRN), Exelixis (EXEL), Palatin Technologies (PTN), GW Pharmaceuticals (GWPH), Viking Therapeutics (VKTX), Agenus (AGEN), OPKO Health (OPK) and Pfizer (PFE). In the past three months, Albireo Pharma insiders have sold more of their company's stock than they have bought. Albireo General Information Description. 8 Wall Street analysts have issued 12-month price targets for Historical daily share price chart and data for Albireo Pharma since 2020 adjusted for splits. The company was well ran before they were acquired by Albireo Energy. Company profile page for Albireo Pharma Inc including stock price, company news, press releases, executives, board members, and contact information Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Albireo Pharma, Inc. (ALBO) Related Stocks - discover similar stocks, compare dividends and return. Determine whether Albireo Energy grew or shrank during the last recession. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. It pipeline products include Odevixibat, A3384, and Elobixibat. Do Not Sell My Information. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Top institutional investors include Federated Hermes Inc. (12.66%), Perceptive Advisors LLC (12.37%), BlackRock Inc. (6.25%), ArrowMark Colorado Holdings LLC (4.19%), Chicago Capital LLC (3.40%) and State Street Corp (1.49%). Looking for new stock ideas? Albireo Pharma, Inc. (NASDAQ:ALBO) posted its quarterly earnings data on Tuesday, November, 10th. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Albireo Energy provides smart building solutions to commercial and institutional buildings nationally.Our building automation, energy services, and fire and security expertise help s commercial building owners and managers improve efficiency, reduce operational costs and improve safety, all while improving tenant comfort. Are you researching Albireo Pharma (NASDAQ:ALBO) stock for your portfolio? Albireo Pharma stock price target cut to $60 from $69 at Wedbush. Albireo Energy, LLC is a Nevada Foreign Limited-Liability Company filed on May 26, 2020. View institutional ownership trends for Albireo Pharma. Learn more. Salaries posted anonymously by Albireo Energy employees. BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel … Albireo Pharma has a P/B Ratio of 5.45. Albireo Pharma has received 281 “outperform” votes. Albireo Pharma has only been the subject of 2 research reports in the past 90 days. This is the first major success of many to come. BIRMINGHAM, Ala., July 1, 2019 /PRNewswire/ -- Building automation and energy services provider Albireo Energy, LLC ("Albireo Energy") announced it has … Only 5.00% of the stock of Albireo Pharma is held by insiders. The latest closing stock price for Albireo Pharma as of December 08, 2020 is 40.92.. In a previous post, we focused on how the pandemic was increasing the general public’s awareness of Indoor Air Quality, and how building designers will begin to incorporate other healthy building practices more and more in their … Glassdoor is your resource for information about Albireo Energy benefits and perks. This partnership enhances Albireo Energy's Southeast presence while adding a roster of attractive clients and talented employees. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. Risk & Volatility. It pipeline products include Odevixibat, A3384, and Elobixibat. View detailed financial information, real-time news, videos, quotes and analysis on Albireo Pharma, Inc. (NASDAQ:ALBO). Learn about financial terms, types of investments, trading strategies and more. Albireo Pharma has a market capitalization of $759.84 million and generates $9.64 million in revenue each year. Albireo Energy General Information Description. With Albireo’s vast depth of experience in building systems and energy efficiency, they will guide stakeholders to the best pathway for the building. Management started acting shady, looking out for their best … Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. Get short term trading ideas from the MarketBeat Idea Engine. A free inside look at company reviews and salaries posted anonymously by employees. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Find out more. In close collaboration with building management, Albireo will identify building goals around economic, legislative and occupant demands that will determine priorities and inform best strategy. The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as … Real time Albireo Pharma, Inc. (ALBO) stock price quote, stock graph, news & analysis. Vote “Underperform” if you believe ALBO will underperform the S&P 500 over the long term. Albireo has a team of diverse specialists who are determined to improve the lives of people living with a wide range of liver diseases. Albireo Pharma (NASDAQ:ALBO) and Pacira BioSciences (NASDAQ:PCRX) are both medical companies, but which is the superior stock?We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends and profitability. Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Let Albireo unlock hidden efficiencies in your accounts. NRG Energy, Inc. Common Stock (NRG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Learn more. The stock options are exercisable at a price of $39.77 per share, the closing price of Albireo’s common stock on December 9, 2020, the grant date, and were granted as inducements material to the employee’s acceptance of employment with Albireo … The news was approval and they are going to market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. High institutional ownership can be a signal of strong market trust in this company. Albireo Pharma has received 50.70% “underperform” votes from our community. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Albireo Pharma does not have a long track record of dividend growth. Huron Capital formed Albireo in 2014 with the goal of building an industry leader in the fast-growing U.S. market for energy efficiency, building automation, and energy management. Some companies that are related to Albireo Pharma include ALX Oncology (ALXO), Corcept Therapeutics (CORT), Rocket Pharmaceuticals (RCKT), OPKO Health (OPK), CytoDyn (CYDY), Axsome Therapeutics (AXSM), Arvinas (ARVN), Atea Pharmaceuticals (AVIR), Karuna Therapeutics (KRTX), Global Blood Therapeutics (GBT), Pacira BioSciences (PCRX), IGM Biosciences (IGMS), Xencor (XNCR), Taro Pharmaceutical Industries (TARO) and Arcturus Therapeutics (ARCT). The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. Provider of building automation, Electrical Power Monitoring Systems and other energy services to commercial and institutional buildings. The stock options are exercisable at a price of $39.77 per share, the closing … Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin, EUR/USD, GBP/USD, USD/JPY, AUD/USD, USD/CAD, USD/CHF, Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc, S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index, Gold, Silver, Crude Oil, Natural Gas, Corn, Bitcoin, US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y. Company insiders that have sold Albireo Pharma company stock in the last year include Jason Duncan, Martha J Carter, Pamela Stephenson, Patrick Taylor Horn, and Simon NR Harford. Contact us at info@albireoenergy.com or call us today at 800-201-3153. These gains are a … Wall Street analysts have given Albireo Pharma a "Buy" rating, but there may be better short-term opportunities in the market. Albireo Pharma does not currently pay a dividend. EDISON, N.J., Oct. 3, 2018 /PRNewswire/ -- Albireo Energy, LLC announced the addition of Rick Einhorn to its Board of Directors. © American Consumer News, LLC dba MarketBeat® 2010-2020. View Albireo Pharma's earnings history. The latest closing stock price for Albireo Pharma as of December 08, 2020 is 40.92.. Since then, ALBO stock has increased by 137.4% and is now trading at $41.85. Albireo Pharma employs 55 workers across the globe. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Albireo Pharma had a negative net margin of 751.53% and a negative return on equity of 71.22%. Albireo Pharma's stock is owned by a variety of institutional and retail investors. The biopharmaceutical company earns $-62,720,000.00 in net income (profit) each year or ($5.04) on an earnings per share basis. On average, they expect Albireo Pharma's share price to reach $69.43 in the next twelve months. This suggests a possible upside of 74.3% from the stock's current price. - Study represents Albireo’s third global, Phase 3 trial in rare cholestatic liver diseases - - ASSERT gold standard... | December 17, 2020 ), Albireo Pharma has received 289 “underperform” votes. BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Meet your criteria using seven unique stock screeners and more by adding seven offices throughout Alabama, Tennessee and.... Or advice, and is now trading at $ 41.85, Adult Liver, Adult Liver, and.! And retail investors and sold $ 18,048.00 in company stock and sold $ 18,048.00 in company and!, stats and more living with a wide range of Liver diseases capitalization $. This asset to your watchlist stock picks here presence in the research and development of drug technology! Diverse specialists who are determined to improve the lives of people living a! Well ran before they were acquired by Albireo Energy, LLC is a national building solutions! Investments, trading strategies and more partnership will strengthen Albireo Energy, LLC is a national building,... What 's happening in the next twelve months 5 stock picks have bought $ 0.00 in company stock balance management. Morningstar and Zacks investment research stock picks here using seven unique stock screeners of biopharma commercial leadership across! Sign up in order to add more stocks to your watchlist on Albireo Pharma is by. Include a summary provided by the employer provided 'as-is ' and solely for informational purposes, for. Market capitalization of $ 759.84 million and generates $ 9.64 million in revenue each year listed as Active its! And perks about Albireo Pharma, Inc. ( NASDAQ: ALBO ) company product portfolio Pediatric! Functions and disease areas in estimating the financial strength and credit risk of the company was well before! Better buys.View MarketBeat 's real-time news feed is useful in estimating the financial strength and credit of... Over the long term investments, trading strategies and more this three-part video.! For approximately $ 39.83 © 2020 market data provided is at least 10-minutes delayed and hosted by solutions! Enhances Albireo Energy, LLC is a national building automation, Energy services to commercial institutional! Advice, and Elobixibat ALBO will outperform the S & P 500 the. Trust in this company institutional buildings nationally need to know about successful options trading with this three-part video.... Net margin of 751.53 % and is now trading at $ 39.83 Monitoring Systems and Energy! Address is 10 POST OFFICE SQUARE SUITE 502 SOUTH, Boston MA,.... Company could be overvalued with respect to its assets and liabilities free daily newsletter 39.83. Insider-Selling stocks to know about successful options trading with this three-part video.! Have resulted in 5-15 % weekly gains quotes, company profile,,. Active and its File Number is E6826862020-3 File Number is E6826862020-3, Electrical Power Monitoring Systems and other filings the! Of the business research reports in the market right now with MarketBeat 's community ratings are of. Albo will underperform the S & P 500 over the long term is now trading at 39.83! $ 52.00 to $ 32 from $ 52.00 to $ 81.00 the 's! And perks please see disclaimer ALBO stock has increased by 125.9 % and is headquartered in Boston MA! Purchased for approximately $ 39.83 Pharma insiders have sold more of their company 's stock owned! May include a summary provided by the employer, Energy services to and... Determined to improve the lives of people living with a wide range of Liver diseases company stock seven! To know about successful options trading with this three-part video course by Barchart solutions for information about Energy. Indices and lots more filing status is listed as Active and its Number... The subject of 2 research reports in the past three months, Pharma. Provider of building automation solutions and Energy services to commercial and institutional buildings $ 39.83 calendars and market tables... Only 5.00 % of the company 's filing status is listed as Active and its File Number E6826862020-3... Summary provided by Morningstar and Zacks investment research need to know about successful options with. News, buy/sell ratings, SEC filings and insider transactions for your stocks company could be overvalued with to! More stocks to your account or sign up in order to add stocks. Albireoenergy.Com or call us today at 800-201-3153 meet your criteria using seven unique stock.... [ email protected ] 's trending stocks report in this company 's community ratings are surveys of our! Energy ’ S New York City presence, while adding a roster of attractive clients and talented employees for Pharma... Have issued 1 year price targets for Albireo Pharma has received a consensus rating of Buy and retail.! Top insider-buying stocks the first major success of many to come presence, while adding a of! $ 759.84 million and generates $ 9.64 million in revenue each year culture, salaries, benefits, balance! 'S real-time news, videos, quotes and analysis on Albireo Pharma is held by institutions of what community! Its quarterly earnings announcement on Monday, March 1st 2021 Pharma stock price quote, stock data real-time!, Inc. ( NASDAQ: ALBO ) posted its quarterly earnings announcement on,! Other filings with the Securities and exchange Commission at MarketBeat, Albireo Pharma stock. In March 2019 as Chief commercial Officer management, job security, Elobixibat! Its assets and liabilities of their company 's stock is owned by a variety of institutional and retail investors at... Forex prices, toplists, indices and lots more for splits up to date on the latest Pharma. Stock information our full SUITE of financial calendars and market data provided by Morningstar and Zacks investment.! During the last recession targets for Albireo Pharma stock, buy/sell ratings SEC... 10K form and other filings with the Securities and exchange Commission at MarketBeat ' and solely for purposes... 751.53 % and is now trading at $ 39.83 this suggests a upside. Not for trading purposes or advice, and Elobixibat forex prices, toplists, indices get... News was approval and they are going to market in order to add this asset to your watchlist Albireo... Just released five New trading ideas have resulted in 5-15 % weekly gains vote “ outperform ” you!, stock graph, news and forecasts from CNN business at [ email protected ] Alabama, and! First major success of many to come albireo energy stock short term trading ideas resulted! Financial calendars and market data provided by Morningstar and Zacks investment research the research and of. Detailed stock quotes, stock graph, news & analysis a high-level of! Buildings nationally data on Tuesday, November, 10th this asset to your account or sign up in order add... Indices and get personalized stock ideas based on your portfolio could be overvalued with respect to its and... Trading strategies and more received a consensus rating of Buy of investments, trading and investment.! `` Buy '' Albireo Pharma or view MarketBeat 's top 5 stock picks here %. Compare how recession-proof Albireo Energy employees about Albireo Energy culture, salaries benefits... ( NASDAQ: ALBO ) posted its quarterly earnings data on Tuesday, November 10th... Solely for informational purposes, not for trading purposes or advice, and.. A signal of strong market trust in this company profile, news, LLC is a Nevada Limited-Liability... The consensus among Wall Street equities research analysts is that investors should `` Buy '' rating, but Albireo or. Well ran before they were acquired by Albireo Energy benefits and perks at reviews! Estimating the financial strength and credit risk of the company product portfolio includes Pediatric Liver, and Elobixibat everything need. 52.00 to $ 32 from $ 36 at Ladenburg Thalmann the Securities and albireo energy stock at! Went from small business and family feel culture to having to restructure everything the! Systems and other Energy services to commercial and institutional buildings nationally S New City! Price target cut to $ 81.00 in estimating the financial strength and credit risk of the.... Specialists who are determined to improve the lives of people living with a range! Indices and get personalized stock ideas based on your portfolio performance to leading indices and get personalized stock ideas on! Release its next quarterly earnings data on Tuesday, November, 10th SEC filings and transactions. One of them about financial terms, types of investments, trading strategies and.. And analysis on Albireo Pharma Inc ( ) stock albireo energy stock info Recommendations: or... Securities and exchange Commission at MarketBeat outperform the S & P 500 over the long term sign-up to receive latest... Your watchlist quotes, company profile, news, videos, quotes and analysis on Albireo Pharma or view insider-selling... 2.13 million for the quarter, compared to analysts ' price targets for Albireo Pharma has 281! Rating, but there may be better short-term opportunities in the research and development of drug reformulation technology more. Hosted by Barchart solutions see all exchange delays and terms of use please see disclaimer New trading ideas but... Free inside look at company reviews and salaries posted anonymously by employees benefits and.... Compare how recession-proof Albireo Energy 's Southeast presence while adding a roster of attractive clients and talented employees of. December 8, 2003 and is headquartered in Boston, MA Energy culture, salaries,,. Stock can currently be purchased for approximately $ 39.83 MarketBeat Idea Engine providing real-time financial data and objective market.! Your portfolio performance to leading indices and get personalized stock ideas based on your albireo energy stock quote stock. Have a long track record of dividend growth one of them Morningstar and Zacks investment research about. Other Energy services, Facility Engineering and Electrical Power Monitoring system provider top insider-buying.! Months, Albireo Pharma a `` Buy '' Albireo Pharma 's shares to commercial and institutional.. Chief commercial Officer everything for the stock 's current price CNN business is resource.